Dr. Nicole Lau is an early-career Research Scientist in the areas of cell biology, host-pathogen interactions and molecular biology and completed her PhD training at the world-class Peter Doherty Institute for Infection and Immunity in Melbourne. She furthered her clinical industry experience in a NATA-accredited, Phase 1 bioanalysis unit during the COVID pandemic. Dr. Lau is fully PC3-certified and formed an integral part of the COVID microneutralization team as well as the biomarker analysis team. At Gertrude Biomedical Dr. Lau forms part of the R&D team to develop cell biology screening platforms for the drug discovery pipeline.